MetLife Investment Management’s Confluent CFLT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-18,653
Closed -$564K 2779
2025
Q4
$564K Buy
18,653
+930
+5% +$22.8K ﹤0.01% 1737
2025
Q3
$351K Buy
17,723
+512
+3% +$10.7K ﹤0.01% 1993
2025
Q2
$429K Buy
17,211
+1,986
+13% +$44.8K ﹤0.01% 1754
2025
Q1
$357K Sell
15,225
-33
-0.2% -$956 ﹤0.01% 1889
2024
Q4
$427K Sell
15,258
-348
-2% -$9.33K ﹤0.01% 1888
2024
Q3
$318K Buy
15,606
+70
+0.5% +$1.57K ﹤0.01% 2033
2024
Q2
$459K Buy
15,536
+3,886
+33% +$112K ﹤0.01% 1768
2024
Q1
$356K Buy
11,650
+430
+4% +$12.1K ﹤0.01% 1867
2023
Q4
$263K Sell
11,220
-154
-1% -$3.72K ﹤0.01% 2079
2023
Q3
$337K Buy
11,374
+6
+0.1% +$201 ﹤0.01% 1869
2023
Q2
$401K Buy
11,368
+3,843
+51% +$108K ﹤0.01% 1845
2023
Q1
$181K Buy
7,525
+17
+0.2% +$394 ﹤0.01% 2279
2022
Q4
$167K Sell
7,508
-197
-3% -$4.56K ﹤0.01% 2361
2022
Q3
$183K Buy
7,705
+5
+0.1% +$135 ﹤0.01% 2353
2022
Q2
$179K Buy
+7,700
New +$207K ﹤0.01% 2398

Other funds holding CFLT

MetLife Investment Management's CFLT Position: Q1 2026 in Review

MetLife Investment Management sold out of Confluent (CFLT) in Q1 2026, closing a stake of 18,653 shares — an estimated $564K sold.

MetLife Investment Management first reported a position in CFLT in Q2 2022 and held it in 15 quarters. The position peaked at $564K in Q4 2025. 4 funds tracked by Wall St. Rank hold CFLT as of Q1 2026.

  • MetLife Investment Management reported no remaining Confluent position as of Q1 2026 after selling out during the quarter.
  • MetLife Investment Management sold 18,653 Confluent shares in Q1 2026, an estimated $564K.
  • MetLife Investment Management first reported a position in Confluent in Q2 2022 and held it in 15 quarters.
  • MetLife Investment Management's Confluent position peaked at $564K in Q4 2025.
  • 4 funds tracked by Wall St. Rank held Confluent as of Q1 2026.

Based on MetLife Investment Management's 13F filing for Q1 2026, filed 14 May 2026.